---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-004406"
form_type: "8-K"
ticker: "ITGR"
cik: "0001114483"
company_name: "Integer Holdings Corp"
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T07:08:07.773827+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Integer appoints Michael Coyle to Board; brings 40+ years medtech leadership

## Summary
- Michael Coyle appointed to Integer's Board of Directors effective July 10, 2025.
- Coyle most recently served as president/CEO of iRhythm Technologies; prior roles at Medtronic, St. Jude Medical, and Eli Lilly.
- He will serve on Audit, Compensation & Organization, and Technology Strategy Committees.
- Board size increased to 11 directors; Coyle's term runs until next annual meeting.
- Coyle holds a Wharton MBA and six U.S. patents related to cardiovascular medical devices.

## SEC filing metadata
- accession: 0001171843-25-004406
- form_type: 8-K
- ticker: ITGR
- cik: 0001114483
- company_name: Integer Holdings Corp
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1114483/000117184325004406/0001171843-25-004406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1114483/000117184325004406/f8k_071025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-004406
- JSON: https://secwatch.observer/filing/0001171843-25-004406.json
- Plain text: https://secwatch.observer/filing/0001171843-25-004406.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.